NO20006323L - Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse - Google Patents

Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse

Info

Publication number
NO20006323L
NO20006323L NO20006323A NO20006323A NO20006323L NO 20006323 L NO20006323 L NO 20006323L NO 20006323 A NO20006323 A NO 20006323A NO 20006323 A NO20006323 A NO 20006323A NO 20006323 L NO20006323 L NO 20006323L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
derivatives
glycopeptide
glycopeptide derivatives
Prior art date
Application number
NO20006323A
Other languages
English (en)
Other versions
NO326066B1 (no
NO20006323D0 (no
Inventor
J Kevin Judice
Paul Ross Fatheree
Bernice M T Lam
Michael R Leadbetter
Martin Sheringham Linsell
Yongqi Mu
Sean Gary Trapp
Guang Yang
Yan Zhu
Original Assignee
Advanced Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medicine Inc filed Critical Advanced Medicine Inc
Publication of NO20006323D0 publication Critical patent/NO20006323D0/no
Publication of NO20006323L publication Critical patent/NO20006323L/no
Publication of NO326066B1 publication Critical patent/NO326066B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20006323A 1998-12-23 2000-12-12 Glykopeptid-derivater, farmasøytiske sammensetninger samt anvendelser derav. NO326066B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11372898P 1998-12-23 1998-12-23
US12931399P 1999-04-14 1999-04-14
US16402499P 1999-11-04 1999-11-04
US16997899P 1999-12-10 1999-12-10
PCT/US1999/030543 WO2000039156A1 (en) 1998-12-23 1999-12-22 Glycopeptide derivatives and pharmaceutical compositions containing the same

Publications (3)

Publication Number Publication Date
NO20006323D0 NO20006323D0 (no) 2000-12-12
NO20006323L true NO20006323L (no) 2001-02-12
NO326066B1 NO326066B1 (no) 2008-09-08

Family

ID=27493926

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006323A NO326066B1 (no) 1998-12-23 2000-12-12 Glykopeptid-derivater, farmasøytiske sammensetninger samt anvendelser derav.

Country Status (23)

Country Link
US (9) US6392012B1 (no)
EP (1) EP1140993B1 (no)
JP (1) JP4362017B2 (no)
KR (1) KR100665204B1 (no)
CN (1) CN1249081C (no)
AT (1) ATE242783T1 (no)
AU (1) AU768204B2 (no)
BR (1) BRPI9914221B8 (no)
CA (1) CA2336445C (no)
CZ (1) CZ301184B6 (no)
DE (1) DE69908819T2 (no)
DK (1) DK1140993T3 (no)
ES (1) ES2201825T3 (no)
HK (1) HK1040721B (no)
HU (1) HU230190B1 (no)
IL (2) IL140093A0 (no)
NO (1) NO326066B1 (no)
NZ (1) NZ508594A (no)
PL (1) PL198311B1 (no)
PT (1) PT1140993E (no)
SI (1) SI1140993T1 (no)
WO (1) WO2000039156A1 (no)
ZA (1) ZA200007222B (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE242783T1 (de) * 1998-12-23 2003-06-15 Theravance Inc Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
US6518243B1 (en) * 1999-04-02 2003-02-11 Trustees Of Princeton University Desleucyl glycopeptide antibiotics and methods of making same
AU2001238020A1 (en) * 2000-02-04 2001-08-14 Advanced Medicine, Inc. Glycopeptide derivatives having antibiotic activity
JP4713810B2 (ja) 2000-05-02 2011-06-29 セラヴァンス， インコーポレーテッド グリコペプチドに対する還元的アルキル化プロセス
US6770621B2 (en) * 2000-05-02 2004-08-03 Theravance, Inc. Polyacid glycopeptide derivatives
EP1278549B1 (en) 2000-05-02 2008-12-10 Theravance, Inc. Composition containing a cyclodextrin and a glycopeptide antibiotic
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
US6828299B2 (en) 2000-06-22 2004-12-07 Theravance, Inc. Polyhydroxy glycopeptide derivatives
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
ATE388960T1 (de) * 2000-06-22 2008-03-15 Theravance Inc Glykopeptidderivate mit carboxysacchariden
US6905669B2 (en) * 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
TWI312785B (en) 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
DE60118737T2 (de) 2001-09-19 2006-10-19 The Procter & Gamble Company, Cincinnati Farbbedruckte Mehrschichtstruktur, ein damit hergestellter absorbierender Artikel und Verfahren zu deren Herstellung
TWI335332B (en) 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
US20040033986A1 (en) 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
CN101404986B (zh) 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
WO2003099858A1 (en) 2002-05-24 2003-12-04 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
WO2003106399A2 (en) 2002-06-17 2003-12-24 Theravance, Inc. PROCESS FOR PREPARING N-PROTECTED β-AMINO ALDEHYDE COMPOUNDS
KR20050047519A (ko) * 2002-07-09 2005-05-20 파스젠, 엘엘씨. 사람 및 동물에서의 미생물 감염의 치료방법
US20050090433A1 (en) * 2002-11-18 2005-04-28 Vicuron Pharmaceuticals, Inc Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
DE602004024393D1 (de) 2003-05-23 2010-01-14 Theravance Inc Quervernetzte glycopeptid-cephalosporin-antibiotika
US7067482B2 (en) 2003-07-11 2006-06-27 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
DE102004055582A1 (de) * 2004-11-18 2006-05-24 Bayer Cropscience Ag N-Heterocyclyl-phthalsäurediamide
US8778874B2 (en) 2004-11-29 2014-07-15 National University Corporation Nagoya University Glycopeptide antibiotic monomer derivatives
US8304597B2 (en) 2004-12-15 2012-11-06 The Procter And Gamble Company Method of using an absorbent article having a functional enhancement indicator
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
JP5178520B2 (ja) 2005-09-22 2013-04-10 メディバス エルエルシー 固体ポリマー送達組成物およびその使用法
EP1926780B1 (en) 2005-09-22 2013-08-14 Medivas, LLC Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
WO2007084507A2 (en) * 2006-01-13 2007-07-26 The Scripps Research Institute [ψ[CH2NH]PG4] GLYCOPEPTIDE ANTIBIOTIC ANALOGS
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
KR20100109936A (ko) * 2007-12-26 2010-10-11 리드 테라퓨틱스, 인크. 항박테리아제로서의 신규한 반(半)-합성 글리코펩티드
KR20100109934A (ko) 2007-12-26 2010-10-11 시오노기세야쿠 가부시키가이샤 글리코펩티드 항생 물질 배당화 유도체
US8841440B2 (en) 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
CN101928330B (zh) * 2009-06-26 2013-10-16 上海来益生物药物研究开发中心有限责任公司 一种新的化合物及其应用
EP2688580A4 (en) * 2011-03-24 2015-03-25 Seachaid Pharmaceuticals Inc DERIVATIVES OF VANCOMYCIN
EP2969004B1 (en) 2013-03-15 2026-02-25 Melinta Subsidiary Corp. Delafloxacin for use in treating infections in obese patients
CA2925005A1 (en) * 2013-09-23 2015-03-26 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Vancomycin-sugar conjugates and uses thereof
US20170342110A1 (en) * 2014-12-25 2017-11-30 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Glycopeptides and uses thereof
CN109072271A (zh) * 2016-01-15 2018-12-21 汉堡大学 用于制备鼠李糖基化类黄酮的方法
WO2017132484A1 (en) * 2016-01-28 2017-08-03 ACatechol, Inc. Photo-cleavable primer compositions and methods of use
CN107325159A (zh) * 2016-04-29 2017-11-07 中国科学院上海药物研究所 一类万古霉素衍生物、其制备方法、药物组合物和用途
IL270685B (en) 2017-05-22 2022-09-01 Insmed Inc Cleavable derivatives of lipoglycopeptide and their uses
CN107987131B (zh) * 2017-11-16 2021-03-09 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的化合物、其制备方法和应用
CN108409837B (zh) 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用
NL2023883B1 (en) * 2019-09-24 2021-04-26 Univ Leiden Antibiotic compounds
CN111620931B (zh) * 2020-06-12 2021-12-17 苏州博源医疗科技有限公司 万古霉素衍生物及其制备方法和应用
CN114213284B (zh) * 2022-01-04 2023-08-01 丽珠集团福州福兴医药有限公司 (9h-芴-9-基)-癸基(2-氧代乙基)氨基甲酸甲酯及其合成方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497802A (en) 1983-10-21 1985-02-05 Eli Lilly And Company N-Acyl glycopeptide derivatives
US4914187A (en) 1984-11-13 1990-04-03 Gruppo Lepetit S.P.A Ester derivatives of antibiotic L 17046
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4639433A (en) 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
GB8704847D0 (en) * 1987-03-02 1987-04-08 Lepetit Spa Substituted alkylamides of teicoplanin compounds
FR2632185B1 (fr) * 1988-06-01 1992-05-22 Rhone Poulenc Chimie Silice pour compositions dentifrices compatible notamment avec le zinc
GB8817397D0 (en) * 1988-07-21 1988-08-24 Lepetit Spa N15-alkyl & n15 n15-di-alkyl derivatives of teicoplanin antibiotics carrying functional groups on alkyl side chain
US5534420A (en) 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
ES2083374T3 (es) 1988-12-27 1996-04-16 Lepetit Spa Derivados amidicos en posicion c63 de 34-des(acetilglucosaminil)-34-desoxi-teicoplaninas.
IE64155B1 (en) 1989-03-29 1995-07-12 Lepetit Spa New substituted alkylamide derivatives of teicoplanin
CA2031803C (en) 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
AU647122B2 (en) 1990-05-28 1994-03-17 Gruppo Lepetit S.P.A. C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1992017456A1 (fr) 1991-03-26 1992-10-15 Fujisawa Pharmaceutical Co., Ltd. Derive d'acide amine et sel dudit derive
EP0525499A1 (en) 1991-07-29 1993-02-03 GRUPPO LEPETIT S.p.A. Amide derivatives of antibiotic A 40926
US5750509A (en) 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
AU703106B2 (en) 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
IT1282586B1 (it) 1996-02-08 1998-03-31 Chemical And Biolog Ind Composizioni farmaceutiche per il trattamento biologico delle infezioni dovute a ceppi di enterococcus faecium resistenti agli
AU2341197A (en) 1996-03-21 1997-10-10 Intercardia, Inc. Solid phase lipoglycopeptide library, compositions and methods
CA2251086C (en) 1996-04-12 2007-02-20 Eli Lilly And Company Glycopeptide compounds
AU2441697A (en) 1996-04-12 1997-11-07 Eli Lilly And Company Covalently-linked glycopeptide dimers
EP0912604B1 (en) 1996-04-23 2001-11-14 Biosearch Italia S.p.A. Improved chemical process for preparing amide derivatives of antibiotic A 40926
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5952466A (en) 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
US5952310A (en) 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
US5977063A (en) 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
US5919771A (en) 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
US6518242B1 (en) * 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
CA2318394A1 (en) 1998-02-20 1999-08-26 Advanced Medicine, Inc. Novel antibacterial agents
ATE361931T1 (de) 1998-05-01 2007-06-15 Lilly Co Eli N1 modifizierte glycopeptide
EP1095058A4 (en) 1998-07-14 2003-07-16 Univ Princeton GLYCOPEPTIDANTIBIOTICS, COMBINATIONAL LIBRARIES OF GLYCOPEPTIDANTIBIOTICS AND METHOD FOR THEIR PRODUCTION
ATE242783T1 (de) * 1998-12-23 2003-06-15 Theravance Inc Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
WO2003099858A1 (en) * 2002-05-24 2003-12-04 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
US7067482B2 (en) * 2003-07-11 2006-06-27 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics

Also Published As

Publication number Publication date
NO326066B1 (no) 2008-09-08
KR100665204B1 (ko) 2007-01-04
HUP0400887A2 (hu) 2004-08-30
US6455669B1 (en) 2002-09-24
NO20006323D0 (no) 2000-12-12
WO2000039156A1 (en) 2000-07-06
CN1315961A (zh) 2001-10-03
PT1140993E (pt) 2003-10-31
CZ301184B6 (cs) 2009-12-02
ES2201825T3 (es) 2004-03-16
BRPI9914221B8 (pt) 2021-05-25
JP4362017B2 (ja) 2009-11-11
EP1140993B1 (en) 2003-06-11
BR9914221B1 (pt) 2013-12-31
KR20010085857A (ko) 2001-09-07
US20060241024A1 (en) 2006-10-26
PL198311B1 (pl) 2008-06-30
ATE242783T1 (de) 2003-06-15
CZ200122A3 (en) 2001-06-13
CA2336445A1 (en) 2000-07-06
DE69908819T2 (de) 2004-05-06
EP1140993A1 (en) 2001-10-10
HUP0400887A3 (en) 2012-09-28
US20040204346A1 (en) 2004-10-14
US6444786B1 (en) 2002-09-03
IL140093A0 (en) 2002-02-10
HK1040721A1 (en) 2002-06-21
HK1040721B (en) 2003-10-17
AU768204B2 (en) 2003-12-04
US20030060598A1 (en) 2003-03-27
NZ508594A (en) 2003-05-30
US7351791B2 (en) 2008-04-01
US6949681B2 (en) 2005-09-27
US20090215982A1 (en) 2009-08-27
HU230190B1 (hu) 2015-09-28
AU3127300A (en) 2000-07-31
IL140093A (en) 2006-06-11
JP2002533472A (ja) 2002-10-08
CN1249081C (zh) 2006-04-05
US7723470B2 (en) 2010-05-25
CA2336445C (en) 2011-07-19
US20080103292A1 (en) 2008-05-01
DK1140993T3 (da) 2003-10-06
US7101964B2 (en) 2006-09-05
ZA200007222B (en) 2002-03-06
SI1140993T1 (en) 2003-12-31
US6392012B1 (en) 2002-05-21
US20050239690A1 (en) 2005-10-27
BR9914221A (pt) 2001-06-26
US6962970B2 (en) 2005-11-08
US8030445B2 (en) 2011-10-04
PL348451A1 (en) 2002-05-20
DE69908819D1 (de) 2003-07-17

Similar Documents

Publication Publication Date Title
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
TR200101126T2 (tr) İkameli fenil türevleri, hazırlanma ve kullanımları
EA199900373A2 (ru) Фармацевтические композиции
EA200300050A1 (ru) Гликопептидфосфонатные производные
DK1200418T3 (da) Nematodicide trifluorbutener
ES2243579T3 (es) Derivados de pirazolopirideno.
NO20012727D0 (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
BR9813719A (pt) Agentes terapêuticos
BR9902084A (pt) Heterociclos.
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
AU2002248531A1 (en) Pyrazolopyriadine derivatives
SE9904128D0 (sv) Novel compounds
DE69936052D1 (de) N1 modifizierte glycopeptide
ATE282608T1 (de) Chinoxalindionen
NO20002321L (no) Bifenylderivater som farmasøytiske midler
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
MY123217A (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
ATE459368T1 (de) Glycopeptid-antibiotika
ECSP993299A (es) Derivados glicopeptidicos y composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAVANCE BIOPHARMA R&D IP, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAVANCE BIOPHARMA ANTIBIOTICS IP, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: CUMBERLAND PHARMACEUTICALS INC., US

MK1K Patent expired